Kadmon Holdings, Inc.
KDMNDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557142
Kadmon Holdings, Inc. was delisted in 2021; its insiders filed their last Form 4 on Nov 9, 2021; 169 institutions reported holding it in 13F filings for Q3 2021, worth $1.37B in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 169
- Q3 2021, +26 vs. previous quarter
- 13F value
- $1.37B
- Reported value at the end of Q3 2021
- Superinvestors holding
- 0
- At the end of Q3 2021
Superinvestors holding KDMN, Q3 2021
No superinvestor reported holding KDMN at the end of Q3 2021.
Latest insider trades
Open-market purchases and sales by Kadmon Holdings, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Kadmon Holdings, Inc. insiders are on file.
Top 10 13F holders, Q3 2021
The largest institutional positions in Kadmon Holdings, Inc. at the end of Q3 2021; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 14,798,802 | $128.9M | 0.00% | −1,135,508−7.1% | Reduced |
| Point72 Asset Management, L.P. | 14,483,586 | $126.2M | 0.60% | +3,971,986+37.8% | Added |
| Magnetar Financial LLC | 9,871,249 | $86.0M | 0.88% | +9,871,249 | New |
| Vanguard Group Inc | 8,980,438 | $78.2M | 0.00% | +57,204+0.6% | Added |
| State Street Corp | 7,681,990 | $66.9M | 0.00% | −2,929,947−27.6% | Reduced |
| Versor Investments LP | 7,511,591 | $65.4M | 2.01% | +7,511,591 | New |
| Morgan Stanley | 5,975,607 | $52.0M | 0.01% | +709,565+13.5% | Added |
| Alpine Associates Management Inc. | 5,721,123 | $49.8M | 1.62% | +5,721,123 | New |
| Omni Partners US LLC | 5,453,368 | $47.5M | 2.44% | +5,453,368 | New |
| Pentwater Capital Management LP | 4,830,000 | $42.1M | 0.58% | +4,830,000 | New |